简体中文 | 繁體中文 | English

Press Releases

2024-08-29 12:36 Kinaxis Announces Executive Leadership Changes
2024-08-28 16:56 Lubrizol Opens Beauty Research Institute in Shanghai, China
2024-08-28 16:38 USB Implementers Forum (USB-IF) Launches New Conformity Test Program for OEMs/ODMs in Support of EU Common Charger Directive
2024-08-28 16:30 Lifezone Metals Initiates Process for Risk Insurance with U.S. International Development Finance Corporation for the Kabanga Nickel Project in Tanzania
2024-08-28 16:24 Wemade's NIGHT CROWS Reveals Big Update
2024-08-28 16:00 Andersen Global Debuts in Mongolia With Tax Firm
2024-08-28 15:57 Interactive Brokers Introduces Access to Stocks on Bursa Malaysia
2024-08-28 15:32 G2 Risk Solutions Unveils Revolutionary, Single-platform Solution for Seamlessly Integrating Merchant Risk Management
2024-08-28 14:36 Xsolla and Savvy Games Group Sign Memorandum of Understanding to Further Video Game Development in the Middle East
2024-08-28 14:33 ExaGrid Announces Support of Metallic
2024-08-28 11:51 Queen Casino Embarks on a New Journey in Online Gaming as Official Partner of Borussia Mönchengladbach (Graphic: Business Wire)
2024-08-28 11:32 The LYCRA Company’s Pavilion at Intertextile Shanghai Features Sustainable Innovations and Co-Exhibitors
2024-08-28 11:25 Hong Kong After Dark: Dive into Unforgettable Nighttime Experiences This Season
2024-08-28 11:14 BDx Indonesia and NeutraDC Unveil Phase I of Interconnected Data Center Ecosystem: Driving AI Innovation through Strategic Collaboration
2024-08-28 10:11 Philip Morris International’s Swedish Match Affiliate Adding 450 Jobs with $232 Million Investment in Kentucky
2024-08-27 14:45 Balmain Launches Balmain Beauty With a New Luxury Fragrance Collection: Les Éternels
2024-08-27 13:17 Samsara Eco and NILIT Team up to Build World-First Nylon 6,6 Recycling Facility
2024-08-27 11:13 Impress Global Markets with Innovations Featured at CHTF2024
2024-08-26 11:12 Berkshire Hathaway Specialty Insurance Makes Leadership Appointments in Asia
2024-08-26 11:06 European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara® (ustekinumab), for the treatment of multiple chronic inflammatory diseases

Business Wire Weibo

Industries

Latest Releases